text:
INTRODUCING OLIVER JAMES
The world's finest luxury lilos arrive to the UK and Europe
Oliver James introduces the world's finest luxury upholstered pool floats to the UK and Europe, with a heavy focus on craftsmanship, durable materials, and striking fabrics.
Set to redefine the poolside experience, every stylish Oliver James lilo is created to be enjoyed both in and out of the water, thanks to their practicality and high calibre production methods that ensure comfort, durability, and longevity. In addition, to reflect their aspirational price point, all lilos are manufactured with the finest fabrics sourced in Spain and the US, resulting in aesthetically pleasing products of the highest quality possible.
Oliver James draws inspiration from life's beautiful experiences, with a product range consisting of nine lilos within three collections: Lisos, Panama, and Shore. Starting from £730, Lisos is the brand's entry-level line, defined by a classic and tasteful design with a minimalistic approach to the use of clean and bold colours. The Panama collection is constructed with crisp aesthetics in mind, featuring a distinct design that plays with the contrast between fabric and piping, carefully crafted using the finest fabrics sourced from Spain. A staple of the Oliver James range, the Shore collection is inspired by iconic destinations such as the Hamptons and Los Angeles, embodying the traditional design aesthetic of the classic bar stripe for a timeless piece of design that complements a beach or boat décor.
Oliver James pays homage to the childhood of founder Oliver Micklewright, and the summers he spent at his family home in the south of France. Micklewright comments: "When we make a lilo, it isn't just a product to us; it's part of creating time for family to come together and enjoy the simplest and happiest of moments. We want to build an experience around our lilos, and we hope that our customers appreciate them as much as we do. They are made to be loved."
Following a successful launch in Asia, Australia, and the US, Oliver James' handsome pieces of floating furniture are now available to European customers on oliverjameslilos.com, with free express shipping worldwide, as well as duties and taxes included. Easily inflated with a USB rechargeable pump, the lilos also neatly fold into a beautiful tote bag, ready to be taken on vacation.
oliverjameslilos.com @oliverjameslilos
For further information and imagery, please contact:
The Public Platform
oliverjames@thepublicplatform.com
OLIVER JAMES LAUNCHES THE DOUBLE LILO
NUET DRY AQUAVIT, THE WORLD'S FIRST SUPER-PREMIUM AQUAVIT
HIVE AT SELFRIDGES, A NEW HONEY-BASED RESTAURANT WITH ONSITE BEEHIVES
hello@thepublicplatform.com
© 2021 The Public Platform Ltd, registered in England and Wales no. 13392576. All rights reserved.


Our committment to "Enhancing the Profile of the Institute and the Planning Profession" leads NZPI to be proactive in developing a media presence, influencing policy and keeping members aware of latest trends in planning. Here you can find NZPI's most recent media releases, submissions, policy statements and communications to members via our weekly e.newsletter "Planning Focus" and our monthly e.newsletter to NZPI Branches " Branch Out".
Be sure to keep up with the latest via our Facebook and Twitter pages.


text:
«Strip Me» — третій студійний альбом британської поп-співачки Наташи Бедінгфілд. Альбом вийшов 7 грудня 2010.

Список композицій

Strip Me

Strip Me Away
За межами США та Канади альбом Strip Me вийшов під назвою Strip Me Away та мав інакший список композицій.

Чарти

Продажі
У США за перший тиждень релізу було продано майже 10,000 копій альбому.

Історія релізів

Примітки

Альбоми Наташи Бедінгфілд
Альбоми Phonogenic Records
Альбоми Epic Records

redpajama_set_name: RedPajamaWikipedia


text:
Q: Unable to use Else, Maybe problem with visual basic Noob started coding 2 days ago. I need to combine these two if statements so only one IF works at a time. Every time I attempt to add Else, Else If or even End If I receive errors such as Else without IF. Nothing I do seems to work. Thank you for your help.
If Cells(i, 15).Value = "address" Then Result = "Return"
    ActiveSheet.Cells(i, 27).Select
    ActiveCell.Value = Result

    Cells(i, 28).Value = Cells(i, 8).Value + Cells(i, 26).Value

If Cells(i, 15).Value <> "address" Then Result = "Pickup"
    ActiveSheet.Cells(i, 27).Select
    ActiveCell.Value = Result

    Cells(i, 28).Value = Cells(i, 8).Value - Cells(i, 26).Value

redpajama_set_name: RedPajamaStackExchange


Learn more about the first Oura ring.
What does the first Oura ring measure?
Learn more about the sensors of the first Oura ring.
What is the first Oura ring made of?
Learn more about the materials of the first Oura ring.
Does the ring have software and how is it updated?
Learn more about updating the ring firmware.
Learn more about the technical specifications of the first Oura ring.
What sizes and colors are available?
Learn more about the sizes and colors of the first Oura ring.
Learn how to set up the first Oura ring.
Can I wear the ring at the gym?
Learn more about wearing & caring for your first generation Oura ring.
How do I keep the ring clean?
Learn how to take care of your first Oura ring.
Follow these steps to transfer the Oura ring to a new user.
Learn how to take care of your first generation Oura ring when it's not in use.


text:
Home›News›Heartland Hospice is "All In"
Heartland Hospice is "All In"
Megan Hatfield, manager of business development for Heartland Hospice serving The Low Country, reflects on what being "all in" means.
"Clemson head coach, Dabo Swinney, coined the 'all in' phrase with his team. The phrase became the rally cry and a mindset that has since motivated the orange-clad believers. One of those 'all in' believers is our patient, Thomas.
Jill, Heartland RN, had been taking care of Thomas for several weeks. They quickly grew close and Jill became a staple to the Thomas family as she developed trust and rapport with Thomas's wife and son. Over time when Thomas started to decline, he remained comfortable, peaceful and 'all in'.
I was having lunch with Jill and she mentioned Thomas's birthday was coming up. She was planning to visit him and deliver a birthday card. While Jill is a devout Carolina fan (Clemson's biggest rival), I knew she would be 'all in' for his birthday. In true Jill-form, she orchestrated our chaplain, Kevin, and social worker, Linda, to be there with her during the birthday celebration for Thomas. There were big balloons and of course, a special cake with Clemson colors. Jill and Linda wore Carolina shirts to bring a playful rivalry to the party but made sure to also give Thomas Clemson treats inside his Clemson adorned bag to help make his birthday even more special. Shortly after his party, Thomas passed away peacefully at home surrounded by his family and friends.
Kindness costs nothing. Our team goes above and beyond, not just for Thomas, but for all our patients and their families to ensure a meaningful experience with us during their hospice journey. The team is 'all in' every single day and I couldn't be more grateful for them."
Heartland Hospice serving The Low Country, is part of ProMedica, a mission-based, not-for-profit integrated healthcare organization which includes a network of 13 hospitals, 2,600 physicians, a health plan, 335 skilled nursing and rehabilitation centers, memory care communities, home health and hospice agencies. Driven by its Mission to improve health and well-being, ProMedica has been nationally recognized for its advocacy programs and efforts to address social determinants of health. For more information about ProMedica Senior Care facilities, please visit www.promedicaseniorcare.org.
TagsHeartland Hospice
Which Craps Strategies (if any) Actually Work?
Tickets on Sale Now for the 25th ...
Stephen Colbert's Sister Running For Congress
X-Factor Coming to Charleston in 2013
Charleston Filmmakers Win Best Documentary at Reedy Reels Film Festival
Take a Peek at Le Farfalle's New Year's Eve Menu
Quintin's Close-Ups: Marvin Pendarvis & Brady Quirk-Garvan
Patriots Point Selects Larry Murray To Serve As Executive Director

redpajama_set_name: RedPajamaCommonCrawl


Native instruments kontakt 5 library | вконтакте.
Native instruments kontakt 5 v5. 5. 0 free download.
Download free kontakt instruments, sample libraries & patches.
Native instruments the grandeur v1. 2. 0 kontakt [re-up] full.
Free massive presets [1000's of free downloads! ] bassgorilla. Com.
Red giant complete suite 2016 (31. 12. 2016) | mac torrent download.
Скачать vst инструменты торрент | синтезаторы vst скачать.
[request] native instruments komplete 11 ultimate (windows).
Massive by native instruments plugins (vst, au) | splice.
Native instruments discovery series india kontakt: free.
The maverick native instruments, maravilla de piano torrent.
Ambient pads for kontakt 5 (free download) | 99sounds.
Komplete: keys: the giant | products.
The best kontakt libraries in 2017! 131 free & premium downloads.
Native instruments giant (kontakt):: rutracker. Org.
Red giant magic bullet suite 13. 0. 2 | mac torrent download.
Native instruments komplete 11 — самый популярный в мире.
The 25 best piano vst plugins (free downloads included.


text:
Q: Get this error with tabs: Uncaught TypeError: Cannot read property 'click' of null My JS knowledge is quite close to null. I am working on a website and I made some custom tabs. I need the first one to be open by default. Yesterday I added this script to my JS code ( I am working in wordpress by the way) and it worked fine!
<script>
    document.getElementById("defaultOpen").click();
</script>
Yesterday it was working but today I didn't move a thing and no matter what I do it won't work again. In the console I get this error:
Get Uncaught TypeError: Cannot read property 'click' of null
Any ideas what could this be? Why was it working in the past and not now? I tried open in a different browser or to clear the cache but it keeps happening and I am curious on why it worked before and not now and how can I fix this. Does anyone have any suggestions please? I'm a JS noob.
EDIT: None of the past questions these peopel asked solved my problem. So it is not a duplicate.


Nicodemo "Nicky" Scarfo, Jr. and his La Cosa Nostra associate Salvatore Pelullo used some of the millions they illegally siphoned from FirstPlus Financial Group Inc. to buy this airplane.
In a world inhabited by international cyber criminals and violent terrorists, it would be easy to think of La Cosa Nostra—the Mafia—as a throwback to a bygone era. But a recent New Jersey case involving the Lucchese crime family is proof that traditional organized crime can still be a potent threat.
Members and associates of the Lucchese organized crime family—one of the families traditionally associated with La Cosa Nostra (LCN)—were recently sentenced to lengthy prison terms in New Jersey for a financial fraud scheme that illegally netted millions of dollars.
Nicodemo "Nicky" Scarfo, Jr., whose imprisoned father was an LCN crime boss in Philadelphia, was sentenced in July to 30 years in prison for racketeering, securities and wire fraud, and other charges related to the 2007 illegal takeover of FirstPlus Financial Group Inc. (FPFG), a publicly held company in Texas. His associate, Salvatore Pelullo, also received a 30-year term. Brothers William and John Maxwell received 20- and 10-year terms, respectively.
In 2007, Pelullo and Scarfo used threats and other tactics to intimidate and remove FPFG's management and board of directors. They were replaced with Mafia associates, including the Maxwell brothers—William was named special counsel to FPFG, while John became the company's CEO.
"Within several weeks of gaining control," Gilson said, "Pelullo and Scarfo had lined their pockets with $7 million. Before they were arrested in 2011, more than $12 million was illegally funneled to them—money that rightfully belonged to the company's stockholders.
The investigation revealed that between 2007 and 2008, Scarfo received $33,000 per month from FPFG as a "consultant"—at a time when he was on home detention in New Jersey for violating his parole from a previous conviction. The money was being paid to a shell company controlled by Scarfo. Pelullo, using a different shell company, had a similar deal. With their ill-gotten gains, the mobsters purchased an airplane, a yacht, and expensive jewelry.
Using a variety of investigative techniques, including a court-ordered wiretap (monitored by retired FBI agents, some of whom had helped put Scarfo's father behind bars), investigators unraveled the scam with the help of federal partners including the Department of Labor and the Bureau of Alcohol, Tobacco, Firearms, and Explosives. During the more than five-year investigation, a million pages of paper documents were analyzed and the contents of more than 100 computers were searched.
A reward of up to $25,000 has been put forth for information leading to arrests and prosecutions in the murder of Aya Nakano, who was gunned down on June 12, 2013.
A man who advertised illegal anabolic steroids online will be serving time in prison.


text:
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy
Min Soo Kim1,
Nayoung Kim1,2,
Sung Eun Kim1,
Hyun Jin Jo1,
Cheol Min Shin1,
Young Soo Park1,2 &
Dong Ho Lee1,2
The increasing trend of antibiotic resistance requires effective second-line Helicobacter pylori (H. pylori) treatment in high prevalence area of H. pylori. The aim of our study was to evaluate the reinfection rate of H. pylori after second-line treatment that would determine the long-term follow up effect of the rescue therapy.
A total of 648 patients who had failed previous H. pylori eradication on standard triple therapy were randomized into two regimens: 1, esomeprazole (20 mg b.i.d), tripotassium dicitrate bismuthate (300 mg q.i.d), metronidazole (500 mg t.i.d), and tetracycline (500 mg q.i.d) (EBMT) or 2, moxifloxacin (400 mg q.d.), esomeprazole (20 mg b.i.d), and amoxicillin (1000 mg b.i.d.) (MEA). At four weeks after completion of eradication therapy, H. pylori tests were performed with 13C urea breath test or invasive tests. In patients who maintained continuous H. pylori negativity for the first year after eradication therapy, H. pylori status was assessed every year. For the evaluation of risk factors of reinfection, gender, age, clinical diagnosis, histological atrophic gastritis or intestinal metaplasia were analyzed.
The recrudescence rate of the EBMT was 1.7% and of the MEA group 3.3% (p = 0.67). The annual reinfection rate of H. pylori of EBMT was found to be 4.45% and the MEA group 6.46%. Univariate analysis (Log-rank test) showed no association with any clinical risk factor for reinfection.
The long-term reinfection rate of H. pylori stayed low in both of bismuth-containing quadruple therapy and moxifloxacin-based triple therapy; thus reinfection cannot affect the choice of second-line treatment.
Clinical Trial Registration Number NCT01792700
Helicobacter pylori (H. pylori) is a common pathogen of the gastric mucosa. It is estimated that at least 50% of the world's human population has H. pylori infection [1]. Since the majority of patients with H. pylori infection do not have any related clinical disease, routine screening is not considered [2]. However, as the current evidence suggests that H. pylori play a major role in peptic ulcer disease, gastric MALT lymphoma and in gastric cancer [3], screening and treatment in these diseases are recommended in several guidelines [2, 4–7]. In addition, European guidelines recommend eradicating H. pylori infection in first-degree relatives of patients with gastric cancer, in long term NSAIDS or acid suppression users and in patients with functional dyspepsia [4]. According to these guidelines, public health efforts toward eradication will be more effective in H. pylori high prevalence areas. Naturally, it is expected that increasing use of antibiotics must lead to increased resistance of antibiotics. Currently, the most commonly used initial treatment is a triple regimen combining a proton pump inhibitor (PPI) with two antibiotics (clarithromycin and amoxicillin/or metronidazole) for the eradication of H. pylori[2, 4–7]. Although this regimen has been shown to be effective in numerous clinical trials, the most recent data show that the eradication rate has declined to less than 80% worldwide, largely related to development of resistance to clarithromycin [8]. In Korea, the recent eradication rate of this regimen was less than 80% in a long-term follow up study (≥ 5 years) [9, 10]. Therefore, this decreasing eradication rate requires effective second-line treatment. Many clinicians have been using second-line therapy with bismuth-containing quadruple therapy or including fluoroquinolone antibiotics such as levofloxacin and moxifloxacin. In this situation, reinfection of H. pylori will determine the long-term effect of the eradication therapy for H. pylori. If a regimen shows a high reinfection rate, then this eradication therapy should be avoided or strictly used only when absolutely indicated for H. pylori eradication. We reported the long-term annual reinfection rate of H. pylori in standard PPI-based triple therapy to be 3.51% per year in Korea [11]. Now that second-line therapy is frequently used there is increasing interest regarding the reinfection and recrudescence rates after rescue therapy. However, there are few reports regarding the reinfection rate of H. pylori after quadruple therapy [12] and none for quinolone based triple therapy. From this background the aim of our study was to evaluate the reinfection rate of H. pylori after two kinds of second-line treatment over a long-term follow up period. In addition, we investigated the risk factors for reinfection after this second-line treatment.
The schematic flow of this study is shown in Figure 1. This was a prospective study performed between 2003 and 2010 at Seoul National University Bundang Hospital in Korea. A total of 648 patients with persistent H. pylori infection after first-line treatment (PPI-based triple therapy) were enrolled. PPI-based triple therapy included PPI (standard dose), amoxicillin 1 g, and clarithromycin 500 mg, all twice daily, for 7 days. Patients were considered persistent H. pylori infection if 13C-urea breath test (UBT) or invasive H. pylori test (Giemsa histology, CLO test, culture) were positive despite PPI-based triple therapy. Patients were excluded from the study if they had a history of renal or hepatic impairment, previous gastric surgery, pregnancy or lactation, therapy with steroids or non-steroidal anti-inflammatory drugs, or therapy with a proton pump inhibitor (PPI) or antibiotics within four weeks of entry. Between 2003 and 2006, the 44 patients with persistent H. pylori infection were treated with bismuth-containing quadruple therapy. Between 2007 and 2010, 604 patients with persistent H. pylori infection were randomized into two kinds of second-line therapy (bismuth-containing quadruple therapy or moxifloxacin-based triple therapy). However, if the patient preferred one regimen, after sufficient information for side effect and eradication rate of each regimen a change was permitted. Finally, 222 patients were treated for 14 days with esomeprazole 20 mg b.i.d, tripotassium dicitrate bismuthate 300 mg q.i.d, metronidazole 500 mg t.i.d, and tetracycline 500 mg q.i.d (EBMT) as second-line treatment regimen for H. pylori infection. 426 patients were treated for 14 days with moxifloxacin 400 mg q.d, esomeprazole 20 mg b.i.d, and amoxicillin 1000 mg b.i.d (MEA) as second-line treatment regimen for H. pylori infection. At four weeks after completion of the second-line treatment, H. pylori eradication was evaluated by 13C-UBT or invasive tests. Invasive tests were performed in the patients in whom follow up endoscopic examination was necessary for peptic ulcer, adenoma or gastric cancer. H. pylori negative status after eradication was defined as a negative 13C-UBT or all negative of Giemsa stain, CLO test, and culture. Among 222 patients with EBMT eradication therapy and 426 patients with MEA eradication therapy, 169 patients and 308 patients were found to be in eradicated status, respectively (Figure 1).
Schematic study flow chart.
All subjects provided informed consent, and the study protocol was approved by the Ethical Committee at Seoul National University Bundang Hospital. ClinicalTrials.gov registration number is NCT01792700.
Invasive Helicobacter pyloritest (Giemsa histology, CLO test, and culture) and histology
To determine the presence of current H. pylori infection, 10 biopsy specimens were taken from the gastric mucosa at each endoscopy (two biopsy specimens each from the greater curvature of the antrum and body, and three each from the lesser curvature of the antrum and body). Among them, four biopsy specimens (one each from the greater curvature and lesser curvature of the antrum and body) were fixed in formalin, and used for determination of H. pylori infection by Giemsa staining. Another four specimens from the four gastric mucosa areas mentioned above were used for H. pylori culturing. The remaining two specimens from the lesser curvature of the antrum and body were used for the rapid urease test (CLO test; Delta West, Bentley, Australia).
Four of the biopsy specimens used for determination of H. pylori infection were also used for histological evaluation. These specimens were examined for the presence of gastric atrophy and intestinal metaplasia by H&E staining. The presence of atrophy on any of four specimens was diagnosed as gastric atrophy, and the same method was applied to intestinal metaplasia. The definition of atrophy is the loss of appropriate glands including both metaplastic and non-metaplastic atrophy. Both metaplastic and non-metaplastic atrophy can be allocated to one of three grades of severity using grading criteria modeled on those suggested by the original and the updated Sydney System [13].
13C-urea breath test
Patients fasted for 4 h before testing. Then, 100 mg of 13C-urea powder (UBiTkit; Otsuka Pharmaceutical, Tokyo, Japan) was dissolved in 100 mL water and administered orally; a second breath sample was collected 20 min later. The collected samples were analyzed using an isotope-selective, non-dispersive infrared spectrometer (UBiT-IR300; Otsuka Pharmaceutical). The cutoff value used for H. pylori eradication was 2.5‰.
Follow-up of H. pyloritests
All of the eradicated patients received gastroscopy with invasive tests (modified Giemsa stain and CLO test) not only from greater and lesser curvature of antrum but also from body after 1 year. If any one of these tests were positive then the patient was regarded as recrudescence case. After this time the patients were followed up for one year with gastroscopy with invasive tests. However, when the patients preferred 13C-UBT or wanted to receive the gastroscopy every other year it was also accepted because the Korea government national health insurance program recommends biannual endoscopy instead of one year.
The annual reinfection rate (percentage per year) of H. pylori was calculated as (total number of infected patients/ cumulative observation years for all patients) X 100.
SPSS for Windows (version 18.0; SPSS, Inc., an IBM Company, Chicago, Illinois, USA) was used for all statistical analyses. Categorical variables were analyzed using the Pearson chi-square test or Fisher's exact test, and continuous variables were analyzed using independent samples t-test. The risk of H. pylori reinfection with time was estimated using the Kaplan-Meier method. To determine the risk factors for reinfection, we used the log-rank test. Null hypotheses of no difference were rejected if p-values were less than 0.05.
Among eradicated 169 patients in the EBMT group and eradicated 308 patients in the MEA group, 59 patients and 116 patients maintained H. pylori-negative status continuously for one year, respectively (Figure 1). Specifically, 110 patients dropped out in the EBMT group and 192 in the MEA group for the following three reasons: 97 patients in the EBMT group and 167 in the MEA group for not returning for gastroscopy or 13C-UBT after treatment, 12 in the EBMT group and 21 in the MEA group for follow-up duration within 1 year, 1 patient in the EBMT group and 4 in the MEA group for reappearance of H. pylori during 1 year follow-up. Finally, 59 patients and 116 patients in each group maintained H. pylori-negative continuously at one year. The demographic and clinical characteristics of two study groups, who maintained H. pylori-negative continuously at one year after the EBMT or MEA therapy, are summarized in Table 1. Gender, the mean age of the patients, clinical diagnosis, atrophic gastritis, and intestinal metaplasia of the two groups were similar. The enrolled early gastric cancer patients were cured by endoscopic submucosal dissection and follow-up was continuously performed regularly. During long-term follow-up patients in the EBMT or in the MEA group were divided into two groups: reinfected group and continuously eradicated group. The demographic and clinical characteristics of the reinfected and continuously eradicated group are summarized in Table 2. In the EBMT group and MEA group, there was no significant evidence that reinfection of H. pylori was related with gender, the mean age of the patients, clinical diagnosis, atrophic gastritis, and intestinal metaplasia. The H. pylori recrudescence and reinfection rates are shown in Table 3. One patient in the EBMT group and four patients in the MEA group, who were H. pylori positive again at 1 year follow-up, were assigned to recrudescence cases. The rate was calculated at 1.7% (1/60) for the EBMT group and 3.3% (4/120) for the MEA group, and these percentages were not significantly different (p = 0.67). During long-term follow-up 1 year after eradication H. pylori reappeared in 7 (11.9%) of EBMT group and in 19 (16.4%) of MEA group and these percentages were not significantly different depending on each rescue treatment (p = 0.43). Among the reinfected persons no one was belonged to the same household.
Table 1 Baseline demographic and clinical characteristics of subjects who maintained the eradicated state by quadruple therapy (EBMT) or moxifloxacin-based triple therapy (MEA)
Table 2 Baseline demographic and clinical characteristics of study subjects depending on reinfection
Table 3 Reinfection and recrudescence rate of Helicobacter pylori
Long-term follow-up and reinfection rate
The mean duration of follow-up of 59 patients in the EBMT group and 116 in the MEA group was 31.9 months (range: 18–90 months) and 30.4 months (range: 18–59 months). The mean number of H. pylori tests per patient was found to be 2.05 tests for the EBMT group and 2.31 tests for the MEA group (Table 4). Reinfection with H. pylori occurred in 7 of 59 patients of EBMT group (11.9%) and in 19 of 116 patients of MEA group (16.4%) sporadically during the follow-up period. The calculated total annual reinfection rate was found to be 4.45% (7/157.17 patient years X 100) for EBMT and 6.46% (19/294.08 patient years X 100) for MEA.
Table 4 Annual reinfection rate of Helicobacter pylori
Risk factors for reinfection
When the reinfected group (n = 26) and continuously eradicated group (n = 149) were compared in terms of demographic information and clinical characteristics, no statistical differences were found by univariate analysis (Log-rank test), in both groups (Table 5). Specially, there was no significant evidence that reinfection of H. pylori is related with eradication regimen (p = 0.23) (Figure 2).
Table 5 Baseline characteristics of study subjects
Kaplan-Meier curves for Helicobacter pylori reinfection according to regimen.
We performed a prospective study to investigate reinfection rate of H. pylori in patients who had been successfully treated with second-line therapy after an initial failure to eradicate H. pylori. To the best of our knowledge, this is the first report comparing the reinfection rate of EBMT and MEA therapy.
Reinfection is defined as an infection with a new strain of H. pylori that is different from the original strain after complete eradication, while recrudescence is a relapse of original strain, which was temporarily suppressed by eradication therapy [14, 15]. The recurrence rates of H. pylori decrease with time and decline sharply after the first year, and beyond the first year, recurrence rates come close to the rate of natural acquisition of H. pylori infection in adulthood [14, 16, 17]. From these reports the confirmation of continuous H. pylori negativity for the first year after eradication therapy has been accepted as complete eradication [18–20]. Therefore, in our study, reinfection was defined as the situation where tests for H. pylori infection, after continuous H. pylori negativity for the first year after eradication therapy, become positive again at a later stage. In addition, patients, who become H. pylori positive again during 1 year follow-up were classified as recrudescence cases. We could not perfectly distinguish between recrudescence of an original strain and reinfection because DNA analysis of the strain using molecular fingerprinting techniques was not performed. However, this definition is supported by data obtained using DNA analysis that the cause of H. pylori recurrence after first year is reinfection [14].
In the previous study, we reported that annual reinfection in patients received standard PPI-based triple eradication therapy in Korea was 3.51% and the recrudescence rate 4.9% [11]. This result was similar to the mean annual reinfection rate (3.4%), calculated from the studies performed in developed countries [16]. The increase in antimicrobial resistance with the standard triple therapy has led to an increase of alternative therapy. However, there are few reports regarding the reinfection of H. pylori in patients received second-line therapy. In 2006, our group reported the annual reinfection rate after second-line therapy (EBMT) during 1996–2004, at 6.0% per patients-years in Seoul, Korea [12]. In the present long-term follow-up study for up to 90 months we investigated the reinfection rate of EBMT and MEA therapy, performed during 2003–2010 in Gyeonggi province near Seoul, and those rates are 4.45% for EBMT and 6.46% for MEA per year. When eradication has truly been successful, reinfection is associated with the risk of re-exposure to H. pylori. Relatively low reinfection rates might be related to the decrease in prevalence of H. pylori infection [21] and the recent improvement of sanitation conditions in Korea. In addition, when the reinfection rate of these two kinds of rescue therapy were compared, there was no significant difference (p = 0.43). Therefore, we suggest that reinfection cannot affect the choice of second-line treatment.
In our study, recrudescence rate in the EBMT group and MEA group was found to be 1.7% and 3.3%, which appears slightly lower than reported after initial eradication with standard PPI-based triple regimen (4.9%) [11]. This result might be related to the decreasing trend in eradication rate of standard triple therapy in Korea. That is, the eradication rate of per protocol (PP) analysis decreased up to 75.9% in 2006 [9]. Some studies reported that the recurrence of H. pylori infection more frequently occurred in patients treated with a low efficacy regimen than in those treated with a high efficacy regimen, as a result of recrudescence of the organism after temporary suppression, not elimination [14, 16, 22, 23]. In the previous studies, the PP eradication rates were reported at 77.2% for the 7- and 93.6% for the 14 day EBMT regimen [24], and 83.8% for the 7-, 82.6% for the 10- and 79.9% for the 14 day MEA regimen [25]. Our lower recrudescence rate might be related to the higher efficacy of the EBMT and MEA regimens. In addition, there was no difference in the recrudescence rate between EBMT and MEA regimen (p = 0.67).
Limited information exists regarding risk factors for reinfection of H. pylori. Candidate risk factors include younger age [26, 27], infection of close contacts [14, 28], dental plaque [29, 30], and contaminated endoscopic equipment [14, 16, 31]. Other studies did not identify any factors predictive of H. pylori reinfection [32–34]. In the previous study, we reported that male gender and low income were significantly associated with reinfection of H. pylori by multivariate analysis [11]. However, the current study did not identify any predictive factors concerning H. pylori reinfection in the EBMT group and MEA group.
This study is the first study with large sample size and a long-term follow-up period in the investigation of reinfection rate of H. pylori in patients who had been successfully treated with second-line therapy after an initial failure to eradicate H. pylori. However, our study has limitations. First, recrudescence cases could be included in the reinfection cases. Theoretically the fingerprinting should be performed for the differentiation of reinfected and recrudescence. However, we did not perform DNA analysis to identify the strains. In clinical practice, it is not easy to perform DNA analysis. Secondly, despite our efforts to enroll all patients, many patients dropped out from this study, and refused to receive H. pylori tests every year, especially when there was no gastrointestinal symptom.
In summary, in Korea, the long-term reinfection rate of H. pylori stayed low in both bismuth-containing quadruple therapy and moxifloxacin-based triple therapy; thus reinfection cannot affect the choice of second-line treatment.
Go MF: Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002, 16 (Suppl 1): 3-15.
Chey WD, Wong BC: American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007, 102: 1808-1825. 10.1111/j.1572-0241.2007.01393.x.
McColl KE: Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010, 362: 1597-1604. 10.1056/NEJMcp1001110.
Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, et al: Management of Helicobacter pylori infection–the Maastricht IV/ Florence Consensus Report. Gut. 2012, 61: 646-664. 10.1136/gutjnl-2012-302084.
Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, et al: Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009, 24: 1587-1600. 10.1111/j.1440-1746.2009.05982.x.
Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, Uemura N, Murakami K, Satoh K, Sugano K: Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010, 15: 1-20.
Kim N, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS: [Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea]. Korean J Gastroenterol. 2009, 54: 269-278. 10.4166/kjg.2009.54.5.269.
Graham DY, Fischbach L: Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010, 59: 1143-1153. 10.1136/gut.2009.192757.
Chung JW, Lee GH, Han JH, Jeong JY, Choi KS, Kim do H, Jung KW, Choi KD, Song HJ, Jung HY, et al: The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea. Hepato-gastroenterology. 2011, 58: 246-250.
Chung WC, Lee KM, Paik CN, Lee JR, Jung SH, Kim JD, Han SW, Chung IS: [Inter-departmental differences in the eradication therapy for Helicobacter pylori infection: a single center study]. Korean J Gastroenterol. 2009, 53: 221-227.
Kim MS, Kim N, Kim SE, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, et al: Long-term Follow-up Helicobacter Pylori Reinfection Rate and Its Associated Factors in Korea. Helicobacter. 2013, 18: 135-142. 10.1111/hel.12018.
Cheon JH, Kim N, Lee DH, Kim JM, Kim JS, Jung HC, Song IS: Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea. Eur J Gastroenterol Hepatol. 2006, 18: 515-519. 10.1097/00042737-200605000-00010.
Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, Leandro G, Price AB, Sipponen P, Solcia E, et al: Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther. 2002, 16: 1249-1259. 10.1046/j.1365-2036.2002.01301.x.
Zhang YY, Xia HH, Zhuang ZH, Zhong J: Review article: 'true' re-infection of Helicobacter pylori after successful eradication–worldwide annual rates, risk factors and clinical implications. Aliment Pharmacol Ther. 2009, 29: 145-160. 10.1111/j.1365-2036.2008.03873.x.
Cameron EA, Bell GD, Baldwin L, Powell KU, Williams SG: Long-term study of re-infection following successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 2006, 23: 1355-1358. 10.1111/j.1365-2036.2006.02899.x.
Gisbert JP: The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol. 2005, 100: 2083-2099. 10.1111/j.1572-0241.2005.50043.x.
Peitz U, Hackelsberger A, Malfertheiner P: A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs. 1999, 57: 905-920. 10.2165/00003495-199957060-00006.
Bell GD, Powell KU: Helicobacter pylori reinfection after apparent eradication–the Ipswich experience. Scand J Gastroenterol Suppl. 1996, 215: 96-104.
Hildebrand P, Bardhan P, Rossi L, Parvin S, Rahman A, Arefin MS, Hasan M, Ahmad MM, Glatz-Krieger K, Terracciano L, et al: Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology. 2001, 121: 792-798. 10.1053/gast.2001.28018.
Soto G, Bautista CT, Roth DE, Gilman RH, Velapatino B, Ogura M, Dailide G, Razuri M, Meza R, Katz U, et al: Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J infect Dis. 2003, 188: 1263-1275. 10.1086/379046.
Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seo GS, Kim HU, Baik GH, Sin CS, et al: Seroprevalence of Helicobacter pylori in South Korea. Helicobacter. 2007, 12: 333-340. 10.1111/j.1523-5378.2007.00504.x.
Xia HX, Talley NJ, Keane CT, O'Morain CA: Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig Dis Sci. 1997, 42: 1821-1834. 10.1023/A:1018827322470.
Seo M, Okada M, Shirotani T, Nishimura H, Maeda K, Aoyagi K, Sakisaka S: Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan. J clin Gastroenterol. 2002, 34: 129-134. 10.1097/00004836-200202000-00005.
Lee BH, Kim N, Hwang TJ, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, et al: Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea. Helicobacter. 2010, 15: 38-45. 10.1111/j.1523-5378.2009.00735.x.
Yoon H, Kim N, Lee BH, Hwang TJ, Lee DH, Park YS, Nam RH, Jung HC, Song IS: Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate. Helicobacter. 2009, 14: 77-85.
Gomez Rodriguez BJ, Rojas Feria M, Garcia Montes MJ, Romero Castro R, Hergueta Delgado P, Pellicer Bautista FJ, Herrerias Gutierrez JM: Incidence and factors influencing on Helicobacter pylori infection recurrence. Rev Esp Enferm Dig. 2004, 96: 424-627.
Shimizu T, Yarita Y, Kaneko K, Yamashiro Y, Segawa O, Ohkura R, Taneike I, Yamamoto T: Case of intrafamilial Helicobacter pylori reinfection after successful eradication therapy. Pediatr Infect Dis J. 2000, 19: 901-903. 10.1097/00006454-200009000-00024.
Gisbert JP, Arata IG, Boixeda D, Barba M, Canton R, Plaza AG, Pajares JM: Role of partner's infection in reinfection after Helicobacter pylori eradication. Eur J Gastroenterol Hepatol. 2002, 14: 865-871. 10.1097/00042737-200208000-00009.
Karczewska E, Konturek JE, Konturek PC, Czesnikiewicz M, Sito E, Bielanski W, Kwiecien N, Obtulowicz W, Ziemniak W, Majka J, et al: Oral cavity as a potential source of gastric reinfection by Helicobacter pylori. Dig Dis Sci. 2002, 47: 978-986. 10.1023/A:1015017502772.
Kilmartin CM: Dental implications of Helicobacter pylori. J Can Dent Assoc. 2002, 68: 489-493.
Sugiyama T, Naka H, Yachi A, Asaka M: Direct evidence by DNA fingerprinting that endoscopic cross-infection of Helicobacter pylori is a cause of postendoscopic acute gastritis. J Clin Microbiol. 2000, 38: 2381-2382.
Feydt-Schmidt A, Kindermann A, Konstantopoulos N, Demmelmair H, Ballauff A, Findeisen A, Koletzko S: Reinfection rate in children after successful Helicobacter pylori eradication. Eur J Gastroenterol Hepatol. 2002, 14: 1119-1123. 10.1097/00042737-200210000-00013.
Leal-Herrera Y, Torres J, Monath TP, Ramos I, Gomez A, Madrazo-de la Garza A, Dehesa-Violante M, Munoz O: High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection. Am J Gastroenterol. 2003, 98: 2395-2402. 10.1111/j.1572-0241.2003.07708.x.
Thong-Ngam D, Mahachai V, Kullavanijaya P: Incidence of Helicobacter pylori recurrent infection and associated factors in Thailand. J Med Associ Thai. 2007, 90: 1406-1410.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/13/138/prepub
This work was supported by a grant from the National Research Foundation of Korea funded by the Korean Government (2012R1A1A3A04002680) and partly supported by the Seoul National University Budang Hospital Research fund (grants no 02-2010-014). MRCC of Seoul National University Hospital was consulted about the statistical analysis of the present manuscript.
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, South Korea
Min Soo Kim, Nayoung Kim, Sung Eun Kim, Hyun Jin Jo, Cheol Min Shin, Young Soo Park & Dong Ho Lee
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea
Nayoung Kim, Young Soo Park & Dong Ho Lee
Min Soo Kim
Nayoung Kim
Sung Eun Kim
Hyun Jin Jo
Cheol Min Shin
Young Soo Park
Dong Ho Lee
Correspondence to Nayoung Kim.
The authors have no competing of interests to declare.
KN- designed the study and performed the major role of collecting patients; KMS- collected patients' data and wrote the manuscript; KSE- collected patients' data and was involved in editing the manuscript; JHJ- collected patients' data and were involved in editing the manuscript; SCM- collected patients' data and were involved in editing the manuscript; PYS- collected patients' data and were involved in editing the manuscript; LDH- collected patients' data and was involved in editing the manuscript. All authors read and approved the final manuscript.
Kim, M.S., Kim, N., Kim, S.E. et al. Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy. BMC Gastroenterol 13, 138 (2013). https://doi.org/10.1186/1471-230X-13-138
DOI: https://doi.org/10.1186/1471-230X-13-138
Second-line


"Deducing Electron Properties from Hard X-ray Observations" by E P. Kontar, J C. Brown et al.
X-radiation from energetic electrons is the prime diagnostic of flare-accelerated electrons. The observed X-ray flux (and polarization state) is fundamentally a convolution of the cross-section for the hard X-ray emission process(es) in question with the electron distribution function, which is in turn a function of energy, direction, spatial location and time. To address the problems of particle propagation and acceleration one needs to infer as much information as possible on this electron distribution function, through a deconvolution of this fundamental relationship. This review presents recent progress toward this goal using spectroscopic, imaging and polarization measurements, primarily from the Reuven Ramaty High Energy Solar Spectroscopic Imager (RHESSI). Previous conclusions regarding the energy, angular (pitch angle) and spatial distributions of energetic electrons in solar flares are critically reviewed. We discuss the role and the observational evidence of several radiation processes: free-free electron-ion, free-free electron-electron, free-bound electron-ion, photoelectric absorption and Compton backscatter (albedo), using both spectroscopic and imaging techniques. This unprecedented quality of data allows for the first time inference of the angular distributions of the X-ray-emitting electrons and improved model-independent inference of electron energy spectra and emission measures of thermal plasma. Moreover, imaging spectroscopy has revealed hitherto unknown details of solar flare morphology and detailed spectroscopy of coronal, footpoint and extended sources in flaring regions. Additional attempts to measure hard X-ray polarization were not sufficient to put constraints on the degree of anisotropy of electrons, but point to the importance of obtaining good quality polarization data in the future.
Kontar, E P.; Brown, J C.; Emslie, A G.; Hajdas, W; Holman, G D.; Hurford, G J.; Kasparova, J; V. Mallik, P C.; Massone, A M.; McConnell, Mark L.; Piana, M; Schmahl, E J.; and Suarez-Garcia, E, "Deducing Electron Properties from Hard X-ray Observations" (2011). Space Science Reviews. 2.


text:
Q: Query nested JSON structure to find the object having the minimum value in a child array I have the following JSON:
{
  "travelClasses": [
    {
      "fares": [
        {
          "referenceId": "a",
          "fare": {
            "tax": 48.99,
            "totalFare": 519.99,
            "currency": {
              "code": "USD",
              "exchangeRate": 1
            }
          }
        }
      ],
      "availableSeats": 9,
      "type": "Pro",
      "code": "B",
      "name": "UX"
    },
    {
      "fares": [
        {
          "referenceId": "b",
          "fare": {
            "tax": 98.99,
            "totalFare": 119.99,
            "currency": {
              "code": "USD",
              "exchangeRate": 1
            }
          }
        }
      ],
      "availableSeats": 9,
      "type": "Pro",
      "code": "C",
      "name": "UC"
    },
    {
      "fares": [
        {
          "referenceId": "c",
          "fare": {
            "tax": 48.99,
            "totalFare": 819.99,
            "currency": {
              "code": "USD",
              "exchangeRate": 1
            }
          }
        }
      ],
      "availableSeats": 9,
      "type": "Eco",
      "code": "X",
      "name": "US"
    }
  ]
}

I need to query this JSON then I would like to retrieve the object which has the minimum totalFare. In my sample, the second node has the minimum totalFare, so I need to retrieve following JSON's object with something like .ToObject<TravelClass>().
{
  "fares": [
    {
      "referenceId": "b",
      "fare": {
        "tax": 98.99,
        "totalFare": 119.99,
        "currency": {
          "code": "USD",
          "exchangeRate": 1
        }
      }
    }
  ],
  "availableSeats": 9,
  "type": "Pro",
  "code": "C",
  "name": "UC"
}

I checked the Newtonsoft documentation about querying a JObject but I couldn't solve that.
Finally here is the C# code that I tried:
class Program
{
    static void Main(string[] args)
    {
        try
        {
            JObject o = JObject.Parse(@"{
              'travelClasses': [
                {
                  'fares': [
                    {
                      'referenceId': 'a',
                      'fare': {
                        'tax': 48.99,
                        'totalFare': 519.99,
                        'currency': {
                          'code': 'USD',
                          'exchangeRate': 1
                        }
                      }
                    }
                  ],
                  'availableSeats': 9,
                  'type': 'Pro',
                  'code': 'B',
                  'name': 'UX'
                },
                {
                  'fares': [
                    {
                      'referenceId': 'b',
                      'fare': {
                        'tax': 98.99,
                        'totalFare': 119.99,
                        'currency': {
                          'code': 'USD',
                          'exchangeRate': 1
                        }
                      }
                    }
                  ],
                  'availableSeats': 9,
                  'type': 'Pro',
                  'code': 'C',
                  'name': 'UC'
                },
                {
                  'fares': [
                    {
                      'referenceId': 'c',
                      'fare': {
                        'tax': 48.99,
                        'totalFare': 819.99,
                        'currency': {
                          'code': 'USD',
                          'exchangeRate': 1
                        }
                      }
                    }
                  ],
                  'availableSeats': 9,
                  'type': 'Eco',
                  'code': 'X',
                  'name': 'US'
                }
              ]
            }");

            var minFareTravelClassObject = o["travelClasses"]
                .Select(m => m.SelectToken("fares")
                .OrderByDescending(x => x["totalFare"]))
                .FirstOrDefault();
        }
        catch (Exception ex)
        {
            throw;
        }
    }
}

public partial class TravelClass
{
    [JsonProperty("fares")]
    public List<FareElement> Fares { get; set; }

    [JsonProperty("availableSeats")]
    public int AvailableSeats { get; set; }

    [JsonProperty("type")]
    public string Type { get; set; }

    [JsonProperty("code")]
    public string Code { get; set; }

    [JsonProperty("name")]
    public string Name { get; set; }
}

public partial class FareElement
{
    [JsonProperty("referenceId")]
    public string ReferenceId { get; set; }

    [JsonProperty("fare")]
    public FareFare Fare { get; set; }
}

public partial class FareFare
{
    [JsonProperty("tax")]
    public decimal Tax { get; set; }

    [JsonProperty("totalFare")]
    public decimal TotalFare { get; set; }

    [JsonProperty("currency")]
    public Currency Currency { get; set; }
}

public partial class Currency
{
    [JsonProperty("code")]
    public string Code { get; set; }

    [JsonProperty("exchangeRate")]
    public decimal ExchangeRate { get; set; }
}

A: Since you already have classes defined to receive the data, I would suggest deserializing to those and skipping the JObject.  You only need one more class to represent the root level:
public class RootObject
{
    [JsonProperty("travelClasses")]
    public List<TravelClass> TravelClasses { get; set; }
}

You can deserialize like this:
var root = JsonConvert.DeserializeObject<RootObject>(json);

From there you can use a LINQ query to find the TravelClass with the lowest TotalFare:
var bestTravelClass = root.TravelClasses
    .SelectMany(tc => tc.Fares, (tc, f) => new { TravelClass = tc, f.Fare.TotalFare })
    .OrderBy(a => a.TotalFare)
    .Select(a => a.TravelClass)
    .FirstOrDefault();

Fiddle: https://dotnetfiddle.net/8WoW5J


Earlier today, the Miami Dolphins commenced work on the modernization of Sun Life Stadium. The multi-year construction project officially began this morning following a successful vote before the Miami-Dade Board of County Commissioners last Tuesday. The project, which will encompass a host of improvements, including all new seats, a shade canopy, new video boards, and concourse and concession improvements, is expected to be complete by the start of the 2016 football season. Upon completion, Sun Life Stadium will be a best-in-class facility capable of attracting world-class events to South Florida for the next 25 years.


Kent Finlay's skyrocketed aspiring artists for four decades now. You know the names: George Strait. Stevie Ray Vaughan. Todd Snider. James McMurtry. Eric Johnson. The list literally goes on forever. Each songwriter's an unmatched talent with one common thread: Finlay launched their careers from the stage at his legendary Cheatham Street Warehouse in San Marcos, Texas. Finlay's simply the most respected lyrical editor and talent scouter in Texas – not to mention a singular songwriter himself.
"I hope you enjoy reading the story of my friend Kent Finlay. He was a huge part of my early career, and I'm sure it was destiny that we met. We played together, tried to write together, had more than a few beers together and just plain had a lot of fun together. His part of Texas music history is huge. He and his great little honky tonk with indoor toilets gave me and a whole host of others a place to learn our craft and to learn how to be, sing and play music on stage. Thanks, Kent, for believing in the up-and-coming Ace in the Hole Band with a totally unknown singer who had big dreams and for helping make those dreams a reality. I'll never forget those days. Thank you, my friend. You are The Man."


text:
Сфы́нту-Гео́рге (, ,  Шепшисентдьёрдь) — город в центральной Румынии, в регионе Трансильвания, административный центр жудеца Ковасна. Расположен на реке Олт.

История
Сфынту-Георге является одним из старейших городов Трансильвании. Впервые город упоминается в 1332 году. Название города происходит от местного покровителя, святого Георгия.

География и климат
Расположен в юго-восточной части Трансильвании, на обоих берегах реки Олт, в 33 км к северо-востоку от Брашова, 198 км от Бухареста.

Население
На 2007 год население города составляет 61 704 человека.

Сфынту-Георге — город с одним из самых низких показателей доли румын в населении:
 венгры — 75 %
 румыны — 23 %
 цыгане — 1,5 %

Экономика
Экономическое развитие города началось во второй половине XIX века, в области текстильной и табачной промышленностях.

На данный момент в городе развиты: электротехническая, химическая, мебельная и пищевая промышленности.

Города-побратимы
  Веспрем, Венгрия
  Гиватаим, Израиль
  Канижа, Сербия
  Кишкунхалаш, Венгрия
  Кралёвски-Хльмец, Словакия
  Новосибирск, Россия
  Ференцварош, Венгрия
  Цеглед, Венгрия

Примечания

Города Румынии
Ковасна (жудец)


Receive 200% Deposit Bonus funds is available to all the FreshForex Traders an unlimited number of times. The 200% Deposit Bonus Promotion to trade per each deposit of $500 and larger. Deposit your live account with $500 and get $1500 together with the bonus funds to your account today.
Applicable For : All FreshForex clients.
The promotion can be enabled for Classic MT4, Classic MT5 and Market Pro MT4 accounts that are not connected to Deposit Bonus 101% and Cashback. To activate the bonus it is required to: Verify personal data.
Activate promotion on one of the trading account in the Client Area. It is not possible to disable the promotion or change the account for bonus crediting in the future. Bonus amount is 200% for each deposit larger than 500 USD / 500 EUR.


A fire broke out at the Ontario, CA location of International Vehicle Importers. 24 cars were destroyed, and sadly two dogs perished.
Fire destroys warehouse full of Nissan Skylines originally appeared on Autoblog on Tue, 03 May 2016 10:01:00 EST. Please see our terms for use of feeds.


Who is the Colombian bad boy who has triggered a footballing legend?
With Radamel Falcao's international career coming to an end, could this live wire soon be his replacement?
It doesn't take much to upset Kenny Dalglish, especially if you play for Rangers.
Although Alfredo Morelos is beginning to frustrate a wider audience than just his Glasgow rivals.
A yellow which keeps him out of the semi-final of the Scottish Cup against Aberdeen next month.
Young Morelos is a target in Scotland after demonstrating he won't hide from conflict.
20 yellow cards and two reds over his 59 games for showing his aggressive nature.
But are people too focused on his discipline, or lack of it?
He has 26 goals in those 59 games and is arguably Steven Gerrard's most potent attacking asset.
Yet, with Morelos, you do feel he is capable of much much more.
A bullish centre forward perfectly suited to the British game, he was signed for £1million this time last year from HJK Helsinki.
During his time in Finland he would fly home every week, home sick and desperate to see his family.
A problem, that no doubt has continued into his time in Scotland, perhaps explaining some of his on pitch behaviour.
Columbia ever-present Radamel Falcao even reckons Morelos is the successor to his number nine throne internationally.
Morelos is at a crucial point in his career.
He's made his international debut and had a chance to play in Europe, although he was sent off (surprise surprise) against FC Ufa in Rangers' Europa League opener.
Gerrard has remained patient with his man so far this season.
But how much more time can he afford to give? A player worth hanging on to, but is he uncontrollable?
What's actually going on with Benjamin Mendy at Man City?


Parents don't always understand that teaching is based on outcomes. They don't necessarily understand what they are or how they are linked to evaluation as well as to resources. Give them some examples of general and specific outcomes and explain to them what they are and how they work .Remember your sources must be referenced. Don't just write what you believe. Write what is in the guides and official documents.


Amber colored chevrons fabricated of copper and kiln fired with multiple layers of enamel to achieve the color. Each chevron is fired a minimum of 4 times and has enamel on the front and back.
With hand stamped and oxidized detailing, hammered sterling silver rings, and oxidized 20 gauge sterling silver ear wires. Approx 2" long and 1" wide.


text:
On the Ground in a Quiet War: Ben Lerner's The Hatred of Poetry
Reviewed in this essay:
Ben Lerner, The Hatred of Poetry
FSG Originals
$12; 96 pp.
In his fragmented, tantalizing Biographia Literaria, Coleridge makes some extraordinary claims about poetry's capacity to transfigure the world. The poetic imagination, he declares,
reveals itself in the balance or reconciliation of opposite or discordant qualities: of sameness, with difference; of the general, with the concrete; the idea, with the image; the individual, with the representative; the sense of novelty and freshness, with old and familiar objects; a more than usual state of emotion, with more than usual order; judgement ever awake and steady self-possession, with enthusiasm and feeling profound or vehement; and while it blends and harmonizes the natural and the artificial, still subordinates art to nature; the manner to the matter; and our admiration of the poet to our sympathy with the poetry.
This magic dialectic was the sort of power that the Romantics claimed for Poetry. Less than a decade later, Shelley would deem poets "the unacknowledged legislators of the World" in the final line of his "Defence of Poetry," written in response to the now-forgotten Thomas Love Peacock's lame theory that science, not poetry, was the language of the modern world. Peacock in turn was working from the playbook established by Plato, who in The Republic charges poets with being liars and counterfeiters dangerous to the well-ordered state. Jump forward to the present, and you've got George Packer griping in the New Yorker about the putative decline of poetry's ability to speak for all Americans.
The quiet war over poetry has been going on for a long time. Indeed, for Ben Lerner, in his marvelous long essay The Hatred of Poetry, a "rhythm of denunciation and defense" is endemic to the art (6). Uniting millennia of claims and counterclaims is a conviction that the form has immense powers which actual poets rarely (or never) use safely, wisely, or fully. "Hatred" is complicated flavor, and curiously, it is felt even by those who actually like poetry, to say nothing of the majority who don't bother with it at all. As Marianne Moore's speaker quips in in the three-line lyric "Poetry," "I, too, dislike it."
So what gives? Is the poet always "a tragic figure" (8)? What makes poetry, like the humanities in general, "at once powerless and dangerous" (20)? Is it true, as Auden says in his elegy for Yeats, that "poetry makes nothing happen"? What individual text accomplishes all that Coleridge claims poetry can?
Lerner's thesis is that "the fatal problem with poetry" the grand concept is actual poems (23). In other words, the ideals for which poetry, especially lyric, strives—to halt time, to conquer death with exact language, to give an account of the universe at once particular to the poet's consciousness and germane to the lives of all possible readers—are, like most ideals, unreachable. (Sounding a bit Romantic himself, Lerner suggests toward the essay's end that childhood leaves us with a residual memory of imaginative powers that seemed endless, particularly in contrast to the socially contingent language-practice of adulthood.) This frustration sparks polemics like Plato's; it stirs up hazy nostalgia for a time when a poet supposedly could speak for everyone (tendentious critics, Lerner shows, often presume this writer to be Whitman); it provokes mighty defenses, by nature more theory than practice; it compels irony like Moore's; and it motivates Keats's longing in "Ode on a Grecian Urn" for "unheard" melodies and "ditties of no tone." "'Poetry,'" concludes Lerner, "is a word for a kind of value no particular poem can realize: the value of persons, the value of a human activity beyond the labor/leisure divide, a value before or beyond price" (53). Great poems get close to the "virtual" potential of Poetry. But they don't touch it, not quite. Not even Shakespeare speaks with a perfect tongue.
About that world of labor and price: the universe of late-capitalist, televisual consumerism. Lerner argues that because a poetic impulse is vestigial in most people, we associate the idea of verse with the sacred; there is an "implicit connection between poetry and the social recognition of the poet's humanity," and by extension the humanity of whoever is moved by poetry (15). When he claims that "Most of us carry at least a weak sense of a correlation between poetry and human possibility," I feel the pressure of agreement in my chest (13). But like Lerner, I'm a poet, critic, and teacher, part of the choir, whatever reservations I have about the poetic vocation. Ultimately, this is a book for residents in the shrinking colony of print culture, who know Whitman and Plato and actually argue about them, when it strikes me that most literate Americans find few things duller than poetry, if they think about it in the first place. Perhaps the hatred theory doesn't apply when utter indifference short-circuits the fertile "contempt" (Marianne Moore's term) fostered by the perceived gap between Poetry and poems. I hope I'm wrong. I just wish that Lerner had given a more concretely historicized, culturally embedded account of poetry's status.
To be fair, these objections are beyond the essay's scope. They do, however, suggest questions that subsequent critics might try to answer; a more detailed ethnography of poetry's cultural import would be fascinating, though probably also depressing. For now, a reader might look to Lerner's debut novel Leaving the Atocha Station, whose narrator, an American poet in Spain, meditates obsessively on the social, political, and psychological roles of art in a digitizing civilization.
Lerner practices a genial, accessible criticism, the kind of stuff that Dwight Macdonald, Lionel Trilling, and Auden once published, and which George Scialabba and Emily Nussbaum still do. (Kudos to Poetry magazine for recently excerpting Lerner's demolition of Mark Edmundson's claim that current poets are not living up to the standard Whitman supposedly established.) Working within a canon that stretches from Greek antiquity to Sir Philip Sidney's defense of "the planet-like music of poetry" to Claudia Rankine's Citizen, and richly informed by scholarship—the late Allen Grossman is an acknowledged influence—Lerner's criticism is for enthusiastic non-specialists, for general humanists, however small that audience may be. This is a vivid and generous account of "the dialectic of a vocation no less essential for being impossible" (85). The essay invites and gratifies the reader, the prose itself an aesthetic experience.
Reading The Hatred of Poetry, I kept thinking of the late Wallace Stevens poem "The Planet on the Table," whose title echoes Sidney's "planet-like" metaphor. Ariel, representative of the poetic impulse, acknowledges the limits of his songs, but rather than resist this, he treats it as the founding condition of art—that it is neither self-enclosed and timeless nor capable of numinous, universal clarity:
It was not important that they survive.
What mattered was that they should bear
Some lineament or character,
Some affluence, if only half-perceived,
In the poverty of their words,
Of the planet of which they were part.
We might, ironically, need more haters, because the hatred of poetry is not mere dislike, and lyric "poverty" isn't always penniless. One wishes the planet would listen to its beggars.